Pharmacogenomics integrates genomics into drug therapy, enabling personalized medicine tailored to individual genetic profiles. This book explores the genetic basis of drug response, including gene-drug interactions, biomarkers for therapy selection, and the impact of genetic variability on drug efficacy and safety. It covers techniques for genetic testing, the development of pharmacogenomic guidelines, and the implementation of personalized treatment strategies in clinical practice. Aimed at geneticists, pharmacologists, clinicians, and healthcare professionals, the book bridges the gap between genetic research and practical applications in personalized medicine, enhancing therapeutic outcomes and reducing adverse effects.
Julian Herrera is a leading dermatologist specializing in pharmacogenomics and personalized medicine, focusing on tailoring dermatological treatments based on individual genetic profiles. His research investigates how genetic variations influence patient responses to dermatological medications, including efficacy, side effects, and optimal dosing strategies. Julian has authored numerous studies on integrating pharmacogenomic testing into dermatological practice to personalize therapy plans for conditions such as psoriasis, eczema, and acne. He has developed comprehensive pharmacogenomic protocols that inform personalized treatment adjustments based on genetic insights. Role of Excipients in Drug Formulation - Stella Gibson